Fortimedix Surgical news

Fortimedix Surgical announces the U.S. launch of symphonX™ during ACS

The launch event will be held on Tuesday October 18, 2016 at 3pm EDT at Fortimedix Surgical’s booth, #1139, and will feature a presentation by world-renowned surgeon, Santiago Horgan, MD, professor of surgery and chief of minimally invasive surgery at UC San Diego Health.

“We are thrilled to formally launch the symphonX™ Surgical Platform in the U.S., which we believe has the potential to deliver on the promise of single-port surgery and elevate the standard of care in laparoscopy,” said Tom Dempsey, VP Sales of Fortimedix Surgical. “The technology was developed under the engineering code name FMX314 in close collaboration with leading surgeons to ensure that the platform addresses the needs of the medical community, and by extension the patient community. Our early clinical experience underlines its potential for improved patient satisfaction and health outcomes, including fewer port-site complications, less post-operative pain, faster recovery and exceptional cosmesis.”

symphonX™ addresses unmet needs in minimally invasive surgery by providing the medical community with a surgical solution that is small, simple and secure. Emulating conventional, multi-port laparoscopy, makes symphonX™ easy to use and enables surgeons to perform procedural steps ergonomically, allowing for a comfortable and secure single-port approach.

The first two U.S. commercial procedures with symphonX™ were recently performed at UC San Diego Health by Dr. Horgan, following 510(k) clearance in the U.S. and CE Mark approval in Europe. The European commercial launch is planned for 2017.

Related:
Go to the News Index Download as PDF

By using our website you consent to all cookies in accordance with our Cookie Policy.